Skip to main content

Table 5 Percentage of patients on monotherapy at the end of biologic course, according to the biologic treatment course

From: Prevalence of biologics monotherapy in a cohort of patients with Rheumatoid Arthritis in daily clinical practice

 

1st Course

2nd Course

3rd Course

4th Course

Total

Number of patients

79

25

9

2

115

% Patients on biologic monotherapy at the end of the course (95 % CI)

25 (16–36)

52 (31–72)

44 (14–79)

50 (13–99)

33 (24–42)

% Patients on biologic monotherapy at the end of the course due to Medical prescription (95 % CI)

20 (12–31)

40 (21–61)

33 (7–70)

50 (13–99)

25 (17–34)

% Patients biologic monotherapy at the end of the course due to patient’s decision (95 % CI)

5 (1–12)

12 (2.5–31)

11 (0.3–48)

0

8 (4–14)